Zhiwei Cao
2009–2015
A researcher in the Science corpus: 2 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Papers from Zhiwei Cao's perspective
Ordered by how strongly the researchers Zhiwei Cao trusts endorse each paper. Same corpus, a different order for every researcher.
- Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies
- The efficiency of multi-target drugs: the network approach might help drug design. (TIPS - Trends in Pharmacological Sciences)
- Drug repositioning: identifying and developing new uses for existing drugs (Nature reviews. Drug discovery)
- DNA interstrand crosslink repair and cancer (Nature Reviews. Cancer)
- Combinatorial drug therapy for cancer in the post-genomic era (Nature Biotechnology)
- DNMT1 and DNMT3b cooperate to silence genes in human cancer cells (Nature)
- Oral drug absorption enhancement by chitosan and its derivatives. (Advanced Drug Delivery Reviews)
- The problem of synergism and antagonism of combined drugs.
- A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib. (Cancer Cell)
- Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian–human immunodeficiency virus infection (Nature Medicine)
Their papers
- Mechanisms of drug combinations: interaction and network perspectives (2009) — 563 citations
- Combining genomic and network characteristics for extended capability in predicting synergistic drugs for cancer (2015) — 115 citations